Adjuvant ipilimumab for stage III melanoma: the patient voice.
Cancer Care and Epidemiology, Queen's Cancer Research Institute, Queen's University, Kingston, Ontario, Canada. Electronic address: michael.brundage@krcc.on.ca.
Michael
M
Brundage
Cancer Care and Epidemiology, Queen's Cancer Research Institute, Queen's University, Kingston, Ontario, Canada.
Timothy
T
Hanna
D000911:Antibodies, Monoclonal; D006801:Humans; D000074324:Ipilimumab; D008545:Melanoma; D012878:Skin Neoplasms
D000911:Antibodies, Monoclonal; D000074324:Ipilimumab